Mesoblast (MESO) Net Income towards Common Stockholders (2015 - 2023)
Mesoblast's Net Income towards Common Stockholders was -$57.5 million in the year ended Jun 30, 2026, compared with -$102.14 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Net Income towards Common Stockholders (2015 - 2023) Analysis & Trends
From the year ended Jun 30, 2015 onward, Mesoblast has reported Net Income towards Common Stockholders for 12 years.
- The figure for the year ended Jun 30, 2026 marks the highest annual Net Income towards Common Stockholders since the year ended Jun 30, 2018.
- Per Business Quant data, Net Income towards Common Stockholders in earlier years was -$102.14 million in the year ended Jun 30, 2025, -$87.96 million in the year ended Jun 30, 2024, -$81.89 million in the year ended Jun 30, 2023 and -$91.35 million in the year ended Jun 30, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Mesoblast | 1.82 Bn | 1.39 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -21.92 Mn |
| Mar 31, 2023 | -18.60 Mn |
| Dec 31, 2022 | -24.49 Mn |
| Sep 30, 2022 | -16.88 Mn |
| Jun 30, 2022 | -21.46 Mn |
| Mar 31, 2022 | -21.30 Mn |
| Dec 31, 2021 | -25.95 Mn |
| Sep 30, 2021 | -22.65 Mn |
| Jun 30, 2021 | -22.06 Mn |
| Mar 31, 2021 | -26.52 Mn |
| Dec 31, 2020 | -25.69 Mn |
| Sep 30, 2020 | -24.54 Mn |
| Jun 30, 2020 | -32.61 Mn |
| Mar 31, 2020 | -15.26 Mn |
| Dec 31, 2019 | -24.58 Mn |
| Sep 30, 2019 | -5.48 Mn |
| Jun 30, 2019 | -20.73 Mn |
| Mar 31, 2019 | -24.97 Mn |
| Dec 31, 2018 | -24.60 Mn |
| Sep 30, 2018 | -19.50 Mn |
API Access
Mesoblast Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();